Ermenegildo Zegna NV
ZGN
DexCom
DXCM
New Fortress Energy
NFE
Workday
WDAY
eBay
EBAY
US Stock MarketDetailed Quotes
NRIX Nurix Therapeutics
- 19.830
- -0.210-1.05%
Close Dec 20 16:00 ET
- 19.828
- -0.002-0.01%
Post 20:01 ET
1.40BMarket Cap-6.84P/E (TTM)
20.610High19.660Low2.91MVolume19.900Open20.040Pre Close57.95MTurnover5.05%Turnover RatioLossP/E (Static)70.84MShares29.56052wk High3.73P/B1.15BFloat Cap7.65052wk Low--Dividend TTM57.74MShs Float52.380Historical High--Div YieldTTM4.74%Amplitude4.220Historical Low19.886Avg Price1Lot Size
About Nurix Therapeutics Company
Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. The company was founded by John Kuriyan, Michael Rapé, and Arthur Weiss in 2009 and is headquartered in San Francisco, CA.
Company Profile
SymbolNRIX
Company NameNurix Therapeutics
Listing DateJul 24, 2020
Issue Price19.00
Founded2009
CEODr. Arthur T. Sands, M.D.,PhD
MarketNASDAQ
Employees284
Fiscal Year Ends11-30
Address1700 Owens Street,Suite 205
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94158
Phone1-415-660-5320
Websitehttp://www.nurixtx.com
Company Executives
- Name
- Position
- Salary
- Dr. Arthur T. Sands, M.D.,PhD
- Director, President and Chief Executive Officer
- 4.36M
- Hans van Houte
- Chief Financial Officer and Principal Accounting Officer
- 1.61M
- Dr. Christine Ring, J.D.,PhD
- Chief Legal Officer, Chief Compliance Officer and Secretary
- --
- Dr. Gwenn Hansen, PhD
- Chief Scientific Officer
- 1.63M
- Dr. David L. Lacey, M.D.
- Chairman of the Board
- 263.29K
- Anil Kapur
- Director
- --
- Edward C. Saltzman
- Independent Director
- 223.29K
- Dr. Lori Anne Kunkel, M.D.
- Independent Director
- 228.29K
- Julia P. Gregory
- Independent Director
- 238.29K
- Paul M. Silva
- Independent Director
- 225.79K
- Judith A. Reinsdorf, J.D.
- Independent Director
- 225.79K